Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
[The principles of formulating a diagnosis].

Klinicheskaia meditsina

Siliaeva NF, Boĭko IuG.
PMID: 8772120
Klin Med (Mosk). 1996;74(2):76-8.

No abstract available.

Cite
Siliaeva NF, Boĭko IuG. O printsipakh postroeniia diagnoza. [The principles of formulating a diagnosis]. Klin Med (Mosk). 1996;74(2):76-8
Siliaeva, N. F., & Boĭko, I. u. G. (1996). O printsipakh postroeniia diagnoza. [The principles of formulating a diagnosis]. Klinicheskaia meditsina, 74(2), 76-8.
Siliaeva, N F, and Boĭko, Iu G. "O printsipakh postroeniia diagnoza." [The principles of formulating a diagnosis]. Klinicheskaia meditsina vol. 74,2 (1996): 76-8.
Siliaeva NF, Boĭko IuG. O printsipakh postroeniia diagnoza. [The principles of formulating a diagnosis]. Klin Med (Mosk). 1996;74(2):76-8. Russian. PMID: 8772120.
Copy Download .nbib Format: NLM
Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?.

Stem cells translational medicine

Kabat M, Bobkov I, Kumar S, Grumet M.
PMID: 31804767
Stem Cells Transl Med. 2020 Jan;9(1):17-27. doi: 10.1002/sctm.19-0202. Epub 2019 Dec 05.

The number of clinical trials using mesenchymal stem cells (MSCs) has increased since 2008, but this trend slowed in the past several years and dropped precipitously in 2018. Previous reports have analyzed MSC clinical trials by disease, phase, cell...

Cite
Kabat M, Bobkov I, Kumar S, et al. Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?. Stem Cells Transl Med. 2019;9(1):17-27doi: 10.1002/sctm.19-0202.
Kabat, M., Bobkov, I., Kumar, S., & Grumet, M. (2020). Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?. Stem cells translational medicine, 9(1), 17-27. https://doi.org/10.1002/sctm.19-0202
Kabat, Maciej, et al. "Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?." Stem cells translational medicine vol. 9,1 (2020): 17-27. doi: https://doi.org/10.1002/sctm.19-0202
Kabat M, Bobkov I, Kumar S, Grumet M. Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?. Stem Cells Transl Med. 2020 Jan;9(1):17-27. doi: 10.1002/sctm.19-0202. Epub 2019 Dec 05. PMID: 31804767; PMCID: PMC6954709.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries